MORRETTA, Elva

MORRETTA, Elva  

Dipartimento di Farmacia/DIFARMA  

Mostra records
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 1-gen-2023 Morretta, Elva; Ruggiero, Dafne; Belvedere, Raffaella; Petrella, Antonello; Bruno, Ines; Terracciano, Stefania; Monti, Maria Chiara
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 1-gen-2023 Biagioli, Michele; Marchianò, Silvia; Di Giorgio, Cristina; Bordoni, Martina; Urbani, Ginevra; Bellini, Rachele; Massa, Carmen; Sami Ullah Khan, Rana; Roselli, Rosalinda; Chiara Monti, Maria; Morretta, Elva; Giordano, Antonino; Vellecco, Valentina; Bucci, Mariarosaria; Jilani Iqbal, Asif; Saviano, Anella; Ab Mansour, Adel; Ricci, Patrizia; Distrutti, Eleonora; Zampella, Angela; Cieri, Enrico; Cirino, Giuseppe; Fiorucci, Stefano
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2 1-gen-2021 Cassiano, C.; Morretta, E.; Costantini, M.; Fassi, E. M. A.; Colombo, G.; Sattin, S.; Casapullo, A.
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 1-gen-2022 Marchiano, S.; Biagioli, M.; Roselli, R.; Zampella, A.; Di Giorgio, C.; Bordoni, M.; Bellini, R.; Morretta, E.; Monti, M.; Distrutti, E.; Fiorucci, S.
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 1-gen-2022 Marchianò, Silvia; Biagioli, Michele; Roselli, Rosalinda; Zampella, Angela; Di Giorgio, Cristina; Bordoni, Martina; Bellini, Rachele; Urbani, Ginevra; Morretta, Elva; Distrutti, Eleonora; Fiorucci, Stefano; Monti, Maria Chiara
Carbamoyl-phosphate synthase 1 as a novel target of phomoxanthone a, a bioactive fungal metabolite 1-gen-2020 Ceccacci, S.; Deitersen, J.; Mozzicafreddo, M.; Morretta, E.; Proksch, P.; Wesselborg, S.; Stork, B.; Monti, M. C.
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 1-gen-2023 Marchiano, S.; Biagioli, M.; Morretta, E.; Di Giorgio, C.; Roselli, R.; Bordoni, M.; Bellini, R.; Urbani, G.; Massa, C.; Monti, M. C.; Zampella, A.; Distrutti, E.; Fiorucci, S.
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 1-gen-2020 Morretta, E.; Tosco, A.; Festa, C.; Mozzicafreddo, M.; Monti, M. C.; Casapullo, A.
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 1-gen-2023 Monticelli, Maria; Hay Mele, Bruno; Allocca, Mariateresa; Liguori, Ludovica; Lukas, Jan; Monti, Maria Chiara; Morretta, Elva; Cubellis, Maria Vittoria; Andreotti, Giuseppina
Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches 1-gen-2017 Morretta, Elva; Esposito, Roberta; Festa, Carmen; Riccio, Raffaele; Casapullo, Agostino; Monti, Maria Chiara
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 1-gen-2023 Di Giorgio, Cristina; Bellini, Rachele; Lupia, Antonio; Massa, Carmen; Bordoni, Martina; Marchianò, Silvia; Rosselli, Rosalinda; Sepe, Valentina; Rapacciuolo, Pasquale; Moraca, Federica; Morretta, Elva; Ricci, Patrizia; Urbani, Ginevra; Monti, Maria Chiara; Biagioli, Michele; Distrutti, Eleonora; Catalanotti, Bruno; Zampella, Angela; Fiorucci, Stefano
Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid 1-gen-2022 Ferraro, Giusy; Belvedere, Raffaella; Petrella, Antonello; Tosco, Alessandra; Stork, Björn; Salamone, Stefano; Minassi, Alberto; Pollastro, Federica; Morretta, Elva; Monti, Maria Chiara
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 1-gen-2022 Turiello, R.; Capone, M.; Morretta, E.; Monti, M. C.; Madonna, G.; Azzaro, R.; Del Gaudio, P.; Simeone, E.; Sorrentino, A.; Ascierto, P. A.; Morello, S.
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 1-gen-2023 Feoli, Alessandra; Iannelli, Giulia; Cipriano, Alessandra; Milite, Ciro; Shen, Lei; Wang, Zhihao; Hadjikyriacou, Andrea; Lowe, Troy L; Safaeipour, Cyrus; Viviano, Monica; Sarno, Giuliana; Morretta, Elva; Monti, Maria Chiara; Yang, Yanzhong; Clarke, Steven G; Cosconati, Sandro; Castellano, Sabrina; Sbardella, Gianluca
Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone 1-gen-2021 Mitidieri, E.; Vellecco, V.; Brancaleone, V.; Vanacore, D.; Manzo, O. L.; Martin, E.; Sharina, I.; Krutsenko, Y.; Monti, M. C.; Morretta, E.; Papapetropoulos, A.; Caliendo, G.; Frecentese, F.; Cirino, G.; Sorrentino, R.; d'Emmanuele di Villa Bianca, R.; Bucci, M.
Label-Free Quantitative Proteomics to Explore the Action Mechanism of the Pharmaceutical-Grade Triticum vulgare Extract in Speeding up Keratinocyte Healing 1-gen-2022 Morretta, E.; D'Agostino, A.; Cassese, E.; Maglione, B.; Petrella, A.; Schiraldi, C.; Monti, M. C.
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 1-gen-2021 Belvedere, R.; Morretta, E.; Pessolano, E.; Novizio, N.; Tosco, A.; Porta, A.; Whiteford, J.; Perretti, M.; Filippelli, A.; Monti, M. C.; Petrella, A.
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics 1-gen-2021 Morretta, Elva; Belvedere, Raffaella; Petrella, Antonello; Spallarossa, Andrea; Rapetti, Federica; Bruno, Olga; Brullo, Chiara; Monti, Maria Chiara
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 1-gen-2020 Carino, A.; Biagioli, M.; Marchiano, S.; Fiorucci, C.; Bordoni, M.; Roselli, R.; Di Giorgio, C.; Baldoni, M.; Ricci, P.; Monti, M. C.; Morretta, E.; Zampella, A.; Distrutti, E.; Fiorucci, S.
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 1-gen-2022 Di Giorgio, C.; Lupia, A.; Marchiano, S.; Bordoni, M.; Bellini, R.; Massa, C.; Urbani, G.; Roselli, R.; Moraca, F.; Sepe, V.; Catalanotti, B.; Morretta, E.; Monti, M. C.; Biagioli, M.; Distrutti, E.; Zampella, A.; Fiorucci, S.